Market overview

Polyvinylpyrrolidone (PVP, povidone, CAS 9003-39-8) is a water-soluble polymer used as a tablet binder and solubiliser in pharmaceuticals, in hair care and cosmetics, in membranes and as a dispersant, including in lithium-ion battery cathode slurries. Pharmaceutical grades (such as K-30) are highly regulated, so qualified supply carries a premium.

The question this report answers
How much PVP demand comes from pharma, batteries and membranes, and is the published USD 2.8 bn credible?

Market Krystal preliminary estimate (2025)
Credence’s USD 2.8 bn (2024) looks high. Assuming 150-220 kt at USD 7-11/kg, we estimate USD 1.1-2.4 bn. Confidence grade C: no reliable published figure; range built from the stated assumptions and narrowed in the full report.

Market dynamics
– Demand: pharma excipients, personal care, battery dispersants, membranes
– Supply: BASF, Ashland, Boai NKY, Chinese producers
– Price and margin: pharma grades far above technical grades
– Regulation: pharmacopoeia standards

Key figures at a glance (third-party, cited)
– PVP market: USD 2,803 mn (2024) to USD 5,692.2 mn by 2032 at 9.26% CAGR (Credence Research)
– PVP K-30 holds about 45% and powder form about 60% of value; North America about 34%, Asia-Pacific about 32% (Credence Research)
– Key producers named: BASF, Ashland, Boai NKY, Sichuan Tianhua, JH Nanhang (Credence Research)

Recent developments among key stakeholders
– Oct 2026: Evonik is reported to be evaluating an acquisition of Ashland (market value about USD 3.3 bn); private equity firms Advent, Apollo and Carlyle were also named as interested parties (PCI Magazine, citing Reuters and Handelsblatt)

What this means for the market
Ashland is the subject of trade and private-equity interest. Deal teams need product-level data on this market, and customers need to understand what a change of owner means for supply.

How published estimates compare
Credence Research’s 9.26% CAGR is high for a mature excipient and reflects new uses (battery dispersants, membranes) that need separate validation. Market Krystal separates pharma, cosmetic, battery and industrial grades and reconciles with NVP supply.

Strategic scenarios to 2047
– Base: personal care, food and pharma demand grows steadily with incomes in Asia, Africa and Latin America.
– Constrained supply: few qualified producers and pharmacopoeia standards limit new supply; quality incidents can tighten markets.
– Technology transition: clean-label, bio-based and fermentation-derived ingredients replace petrochemical ones where cost allows.
The swing factor for Polyvinylpyrrolidone (PVP) is pharma excipient and battery dispersant demand. Signposts: EU cosmetic regulation updates, clean-label claims, bio-based capacity.

What this report delivers
Annual volume (tonnes) and value (USD) for 2026-2035, segmented by grade: pharma (K-12 to K-90, crospovidone), cosmetic, technical, battery; application: pharmaceuticals, personal care, membranes, battery dispersants, adhesives; region: North America, Asia-Pacific, Europe. Each segment is backed by a producer capacity table, price benchmarks for 2020-2025 by grade and region, trade-flow analysis and a supplier risk map. Companies assessed include BASF, Ashland, Boai NKY, Sichuan Tianhua, JH Nanhang Life Sciences. The 2036-2047 outlook uses three explicit scenarios (base, constrained supply and technology transition) rather than a single extrapolated curve.

Who uses this report
Producers, large buyers, commodity traders and chemical-sector investors.

Why our approach is evidence-based
Most CAS-level market listings publish a single number with no audit trail, and we regularly find figures that contradict their own growth rates or exceed the size of the market they sit inside. Market Krystal works the other way round. We start from physical evidence: plant capacities, production and trade data, company disclosures, regulatory texts and price records. We build volume and price separately and only then compute value. Every third-party figure is cited, every Market Krystal estimate is labelled with its method and a confidence grade, and conflicts between sources are shown rather than hidden. Confidence grades: A = two or more independent sources agree, or government or company data; B = one published estimate checked against volumes or prices; C = no reliable published figure, so the range is built from stated assumptions and narrowed in the full report.

Methodology and delivery
Prepared by the Market Krystal Chemicals Research Team. Each report is built around the buyer’s question: after purchase, a short scope confirmation fixes the priority regions, companies and applications, and the report is delivered within 5-7 business days with the Excel model behind every estimate, so buyers can audit and change the assumptions.

The purchased delivery includes the PDF report, Excel datasets and customization around the buyer’s priority region, company set, application or commercial question.

What this research answers

The study connects production routes, named suppliers, applications, regional demand, trade, pricing drivers and commercial opportunities for this CAS number. Detailed estimates and company analysis remain inside the purchased report.